Search

Your search keyword '"Manca, Claudia"' showing total 300 results

Search Constraints

Start Over You searched for: Author "Manca, Claudia" Remove constraint Author: "Manca, Claudia"
300 results on '"Manca, Claudia"'

Search Results

2. Individual differences in social homeostasis

5. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study

7. Carbapenem-resistant Enterobacterales in solid organ transplant recipients

9. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study

10. Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV

11. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study

12. Anti-neuroinflammatory eects of conjugated linoleic acid isomers, c9,t11 and t10,c12, on activated BV-2 microglial cells..

14. Astrocytic Cannabinoid Receptor 1 Promotes Resilience by Dampening Stress-Induced Blood-Brain Barrier Alterations and Inflammation

15. Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III

17. Embracing tensions throughout crises: The case of an Italian university hospital during the COVID-19 pandemic.

18. Indirect Calorimetry-Based Novel Approach for Evaluating Metabolic Flexibility and Its Association with Circulating Metabolic Markers in Middle-Aged Subjects

19. Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II

20. Identification of Metabolic Biomarkers of Chronic Vagus Nerve Stimulation (VNS) in Subjects with Drug‐Resistant Epilepsy (DRE)

26. Identification of metabolic biomarkers of chronic vagus nerve stimulation (VNS) in subjects with drug‐resistant epilepsy (DRE).

28. Individual differences in social homeostasis

29. Benefit-risk Evaluation for Diagnostics: A Framework (BED-FRAME)

30. Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II

33. Hemp seed significantly modulates the endocannabinoidome and produces beneficial metabolic effects with improved intestinal barrier function and decreased inflammation in mice under a high-fat, high-sucrose diet as compared with linseed

34. Assessment of the effects of dietary vitamin D levels on olanzapine-induced metabolic side effects : focus on the endocannabinoidome-gut microbiome axis

38. Three of a Kind: Control of the Expression of Liver-Expressed Antimicrobial Peptide 2 (LEAP2) by the Endocannabinoidome and the Gut Microbiome

41. Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPARα Agonist Fenofibrate-Treated Mice.

43. Assessment of the Effects of Dietary Vitamin D Levels on Olanzapine-Induced Metabolic Side Effects: Focus on the Endocannabinoidome-Gut Microbiome Axis

48. Assessment of the effects of dietary vitamin D levels on olanzapine-induced metabolic side effects : focus on the endocannabinoidome-gut microbiome axis

49. Circulating fatty acids and endocannabinoidome-related mediator profiles associated to human longevity.

50. Exploring the endocannabinoidome in genetically obese (ob/ob) and diabetic (db/db) mice: Links with inflammation and gut microbiota

Catalog

Books, media, physical & digital resources